Related Experiment Video
Updated: Feb 18, 2026
Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
Published on: December 30, 2016
Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer
Niki Marie Zacharias1,2, Christopher McCullough3, Sriram Shanmugavelandy1
1Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abstract:
The new oncologic paradigm of precision medicine is focused on identifying metabolic, proteomic, transcriptomic and genomic variabilities in tumors that can be exploited to tailor treatments and improve patient outcomes. Metabolic changes are a hallmark of cancer, and inhibition of metabolic pathways is now a major strategy in medicinal chemistry for targeting cancers. However, non-invasive biomarkers to categorize metabolic subtypes are in short supply. The purpose of this study was to characterize the intracellular and extracellular metabolic profiles of four prostate cancer cell lines with varying degrees of aggressiveness. We observed metabolic differences between the aggressive prostate cancer cell line PC3 and the even more aggressive, metastatic subline PC3M assessed by hyperpolarized in vivo pyruvate studies, nuclear magnetic resonance spectroscopy, and carbon-13 feeding studies. On further examination of the differences between these two cell lines, we found increased glutamine utilization in the metastatic PC3M subline that led directly to sensitivity to glutaminase inhibitor CB-839. Our study supports the theory that metastatic progression increases glutamine utilization and the inhibition of glutaminolysis could have clinical implications.
Insights
Metastatic prostate cancer cells show increased glutamine use. Targeting this metabolic vulnerability with glutaminase inhibitors like CB-839 offers a promising precision medicine strategy for advanced cancers.
Area of Science:
- Oncology
- Cancer Metabolism
- Precision Medicine
Background:
- Metabolic reprogramming is a hallmark of cancer, driving tumor growth and progression.
- Precision medicine aims to tailor cancer treatments by targeting specific molecular vulnerabilities.
- Non-invasive biomarkers for categorizing cancer metabolic subtypes are critically needed.
Purpose of the Study:
- To characterize the metabolic profiles of prostate cancer cell lines with varying aggressiveness.
- To identify metabolic differences between aggressive (PC3) and highly metastatic (PC3M) prostate cancer cells.
- To explore the therapeutic potential of targeting identified metabolic pathways.
Main Methods:
- Utilized hyperpolarized in vivo pyruvate studies to assess metabolic activity.
- Employed nuclear magnetic resonance spectroscopy for detailed metabolic profiling.
- Conducted carbon-13 (¹³C) feeding studies to trace metabolic pathways.
- Investigated the effect of glutaminase inhibitor CB-839 on cancer cell lines.
Main Results:
- Observed distinct metabolic differences between PC3 and PC3M prostate cancer cell lines.
- Identified increased glutamine utilization in the more aggressive, metastatic PC3M subline.
- Demonstrated that PC3M cells exhibit sensitivity to the glutaminase inhibitor CB-839.
- Linked metastatic progression to heightened reliance on glutamine metabolism.
Conclusions:
- Metastatic prostate cancer progression is associated with increased glutamine utilization.
- Targeting glutaminolysis represents a potential therapeutic strategy for metastatic prostate cancer.
- Understanding cancer cell metabolism is crucial for developing effective precision medicine treatments.
More Related Videos
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:21Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
01:40Overview of Metabolism
Plant Metabolism
Sunlight, the primary source of energy in plants, is first absorbed by the chlorophyll pigments present in their leaves. Plants then use this energy to carry out photosynthesis, where water is oxidized into oxygen and carbon dioxide...